Validation of the 3-variable prognostic score (3-PS) in mCRPC patients treated with


Journal

Annals of nuclear medicine
ISSN: 1864-6433
Titre abrégé: Ann Nucl Med
Pays: Japan
ID NLM: 8913398

Informations de publication

Date de publication:
Oct 2020
Historique:
received: 30 03 2020
accepted: 03 07 2020
pubmed: 13 7 2020
medline: 3 7 2021
entrez: 13 7 2020
Statut: ppublish

Résumé

Radium-223 ( Four hundred and thirty mCRPC patients treated with Statistical analysis showed that the 3-PS score was valid on the total group as well as in the clean group as the AUC estimated (0.74) falls within the CI of the AUC calculated on the validation sample (95% CI 0.66-0.82). This study confirms the validity of the 3-PS score for mCRPC patients. This score is simple, noninvasive and affordable and can be easily used to select patients that will most probably complete

Identifiants

pubmed: 32654030
doi: 10.1007/s12149-020-01501-7
pii: 10.1007/s12149-020-01501-7
pmc: PMC7515961
doi:

Substances chimiques

Radioisotopes 0
radium Ra 223 dichloride RJ00KV3VTG
Radium W90AYD6R3Q

Types de publication

Journal Article Multicenter Study

Langues

eng

Sous-ensembles de citation

IM

Pagination

772-780

Références

N Engl J Med. 2013 Jul 18;369(3):213-23
pubmed: 23863050
Oncol Lett. 2019 Feb;17(2):1467-1476
pubmed: 30675201
Ann Nucl Med. 2018 Feb;32(2):142-148
pubmed: 29285670
Eur Urol. 2015 Jul;68(1):42-50
pubmed: 25449207
Crit Rev Oncol Hematol. 2017 May;113:43-51
pubmed: 28427521
Ann Oncol. 2017 May 1;28(5):1090-1097
pubmed: 28453701
Oncotarget. 2018 Mar 5;9(22):16197-16204
pubmed: 29662636
Onco Targets Ther. 2018 Dec 17;12:9-13
pubmed: 30588025
Clin Genitourin Cancer. 2017 Feb;15(1):42-52.e8
pubmed: 27613490
BMC Cancer. 2015 May 07;15:371
pubmed: 25948240
Int J Radiat Biol. 2019 May;95(5):554-561
pubmed: 30557063
Curr Probl Cancer. 2019 Jun;43(3):205-212
pubmed: 29983206
Oncologist. 2018 Feb;23(2):193-202
pubmed: 29183960
Aging Clin Exp Res. 2018 Jun;30(6):677-680
pubmed: 28856577
Tumori. 2019 Oct;105(5):367-377
pubmed: 31096849
Urol Oncol. 2018 Jul;36(7):340.e7-340.e21
pubmed: 29706458
Eur J Nucl Med Mol Imaging. 2018 Dec;45(13):2256-2263
pubmed: 29785515
Future Oncol. 2018 Nov;14(27):2821-2832
pubmed: 29905090
J Nucl Med. 2015 Aug;56(8):1177-84
pubmed: 26069307
Aging Clin Exp Res. 2020 May 1;:
pubmed: 32358729
Clin Genitourin Cancer. 2016 Oct;14(5):e529-e533
pubmed: 27212044
Cancer. 1988 Jan 1;61(1):195-202
pubmed: 3334948
Eur J Nucl Med Mol Imaging. 2018 May;45(5):824-845
pubmed: 29234845

Auteurs

Viviana Frantellizzi (V)

Department of Molecular Medicine, "Sapienza" University of Rome, Viale Regina Elena 324, 00161, Rome, Italy. viviana.frantellizzi@uniroma1.it.

Fabio Monari (F)

Radiation Oncology Center, S. Orsola-Malpighi Hospital, Bologna, Italy.

Manlio Mascia (M)

Unit of Nuclear Medicine, "Spirito Santo" Hospital, Pescara, Italy.

Renato Costa (R)

Unit of Nuclear Medicine, Biomedical Department of Internal and Specialist Medicine, University of Palermo, Palermo, Italy.

Giuseppe Rubini (G)

Nuclear Medicine Department, University of Bari "Aldo Moro", Bari, Italy.

Angela Spanu (A)

Unit of Nuclear Medicine, Department of Medical, Surgical and Experimental Sciences, University of Sassari, Sassari, Italy.

Arianna Di Rocco (A)

Department of Public Health and Infectious Diseases, "Sapienza" University of Rome, Rome, Italy.

Elisa Lodi Rizzini (E)

Nuclear Medicine Unit, S. Orsola-Malpighi Hospital, Bologna, Italy.

Luca Cindolo (L)

Department of Urology, "Villa Stuart" Private Hospital, Rome, Italy.

Maria Licari (M)

Unit of Nuclear Medicine, Biomedical Department of Internal and Specialist Medicine, University of Palermo, Palermo, Italy.

Valentina Lavelli (V)

Nuclear Medicine Department, University of Bari "Aldo Moro", Bari, Italy.

Susanna Nuvoli (S)

Unit of Nuclear Medicine, Department of Medical, Surgical and Experimental Sciences, University of Sassari, Sassari, Italy.

Cristina De Angelis (C)

Department of Radiological Sciences, Oncology and Anatomical Pathology, "Sapienza" University of Rome, Rome, Italy.

Valeria Dionisi (V)

Radiation Oncology Center, S. Orsola-Malpighi Hospital, Bologna, Italy.

Cristina Ferrari (C)

Nuclear Medicine Department, University of Bari "Aldo Moro", Bari, Italy.

Giuseppe De Vincentis (G)

Department of Radiological Sciences, Oncology and Anatomical Pathology, "Sapienza" University of Rome, Rome, Italy.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH